Cargando…

CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma

BACKGROUND: The objective of this study investigated the distribution of immature dendritic cells (DCs), Langerhans cells and plasmacytoid DCs in oral submucous fibrosis (OSMF), OSMF associated with oral squamous cell carcinoma (OSMF-OSCC), oral leukoplakia (OL), and oral squamous cell carcinoma (OS...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Luan César, Fonseca, Felipe Paiva, de Almeida, Oslei Paes, Mariz, Bruno Augusto Linhares de Almeida, Lopes, Márcio Ajudarte, Radhakrishnan, Raghu, Sharma, Mohit, Kowalski, Luiz Paulo, Vargas, Pablo Agustin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982989/
https://www.ncbi.nlm.nih.gov/pubmed/31880289
http://dx.doi.org/10.4317/medoral.23177
_version_ 1783491416213684224
author da Silva, Luan César
Fonseca, Felipe Paiva
de Almeida, Oslei Paes
Mariz, Bruno Augusto Linhares de Almeida
Lopes, Márcio Ajudarte
Radhakrishnan, Raghu
Sharma, Mohit
Kowalski, Luiz Paulo
Vargas, Pablo Agustin
author_facet da Silva, Luan César
Fonseca, Felipe Paiva
de Almeida, Oslei Paes
Mariz, Bruno Augusto Linhares de Almeida
Lopes, Márcio Ajudarte
Radhakrishnan, Raghu
Sharma, Mohit
Kowalski, Luiz Paulo
Vargas, Pablo Agustin
author_sort da Silva, Luan César
collection PubMed
description BACKGROUND: The objective of this study investigated the distribution of immature dendritic cells (DCs), Langerhans cells and plasmacytoid DCs in oral submucous fibrosis (OSMF), OSMF associated with oral squamous cell carcinoma (OSMF-OSCC), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC). MATERIAL AND METHODS: Fourteen cases of OSMF, 9 of OSMF-OSCC, 8 of OL¸ 45 of OSCC and 8 of normal epithelium were retrospectively retrieved and their diagnoses confirmed. Immunoreactions against CD1a, CD207 e CD303 were performed and the number of positive cells quantified. RESULTS: A significant decrease of CD1a+ was found in OSMF (p≤0.05), OSMF-OSCC (p ≤ 0.01), and OSCC (p ≤ 0.001) when compared to normal epithelium. For CD207+ the significance decrease was observed in OSMF-OSCC (p ≤ 0.05), and OSCC (p ≤ 0.01) when compared with normal epithelium, and in OSMF when compared with OL (p ≤ 0.05). There was no significant difference for CD303, but increased in CD303+ was observed in OSCC when compared with normal epithelium. CONCLUSIONS: The decrease in the number of CD1a+ and CD207+ cells may be associate to the development of oral OSCC, and in OPMDs they might be indicators of malignant transformation. Key words:Premalignant lesions, oral submucous fibrosis, oral squamous cell carcinoma, immune response.
format Online
Article
Text
id pubmed-6982989
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Medicina Oral S.L.
record_format MEDLINE/PubMed
spelling pubmed-69829892020-01-29 CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma da Silva, Luan César Fonseca, Felipe Paiva de Almeida, Oslei Paes Mariz, Bruno Augusto Linhares de Almeida Lopes, Márcio Ajudarte Radhakrishnan, Raghu Sharma, Mohit Kowalski, Luiz Paulo Vargas, Pablo Agustin Med Oral Patol Oral Cir Bucal Research BACKGROUND: The objective of this study investigated the distribution of immature dendritic cells (DCs), Langerhans cells and plasmacytoid DCs in oral submucous fibrosis (OSMF), OSMF associated with oral squamous cell carcinoma (OSMF-OSCC), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC). MATERIAL AND METHODS: Fourteen cases of OSMF, 9 of OSMF-OSCC, 8 of OL¸ 45 of OSCC and 8 of normal epithelium were retrospectively retrieved and their diagnoses confirmed. Immunoreactions against CD1a, CD207 e CD303 were performed and the number of positive cells quantified. RESULTS: A significant decrease of CD1a+ was found in OSMF (p≤0.05), OSMF-OSCC (p ≤ 0.01), and OSCC (p ≤ 0.001) when compared to normal epithelium. For CD207+ the significance decrease was observed in OSMF-OSCC (p ≤ 0.05), and OSCC (p ≤ 0.01) when compared with normal epithelium, and in OSMF when compared with OL (p ≤ 0.05). There was no significant difference for CD303, but increased in CD303+ was observed in OSCC when compared with normal epithelium. CONCLUSIONS: The decrease in the number of CD1a+ and CD207+ cells may be associate to the development of oral OSCC, and in OPMDs they might be indicators of malignant transformation. Key words:Premalignant lesions, oral submucous fibrosis, oral squamous cell carcinoma, immune response. Medicina Oral S.L. 2020-01 2019-12-24 /pmc/articles/PMC6982989/ /pubmed/31880289 http://dx.doi.org/10.4317/medoral.23177 Text en Copyright: © 2020 Medicina Oral S.L. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
da Silva, Luan César
Fonseca, Felipe Paiva
de Almeida, Oslei Paes
Mariz, Bruno Augusto Linhares de Almeida
Lopes, Márcio Ajudarte
Radhakrishnan, Raghu
Sharma, Mohit
Kowalski, Luiz Paulo
Vargas, Pablo Agustin
CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma
title CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma
title_full CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma
title_fullStr CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma
title_full_unstemmed CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma
title_short CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma
title_sort cd1a+ and cd207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982989/
https://www.ncbi.nlm.nih.gov/pubmed/31880289
http://dx.doi.org/10.4317/medoral.23177
work_keys_str_mv AT dasilvaluancesar cd1aandcd207cellsarereducedinoralsubmucousfibrosisandoralsquamouscellcarcinoma
AT fonsecafelipepaiva cd1aandcd207cellsarereducedinoralsubmucousfibrosisandoralsquamouscellcarcinoma
AT dealmeidaosleipaes cd1aandcd207cellsarereducedinoralsubmucousfibrosisandoralsquamouscellcarcinoma
AT marizbrunoaugustolinharesdealmeida cd1aandcd207cellsarereducedinoralsubmucousfibrosisandoralsquamouscellcarcinoma
AT lopesmarcioajudarte cd1aandcd207cellsarereducedinoralsubmucousfibrosisandoralsquamouscellcarcinoma
AT radhakrishnanraghu cd1aandcd207cellsarereducedinoralsubmucousfibrosisandoralsquamouscellcarcinoma
AT sharmamohit cd1aandcd207cellsarereducedinoralsubmucousfibrosisandoralsquamouscellcarcinoma
AT kowalskiluizpaulo cd1aandcd207cellsarereducedinoralsubmucousfibrosisandoralsquamouscellcarcinoma
AT vargaspabloagustin cd1aandcd207cellsarereducedinoralsubmucousfibrosisandoralsquamouscellcarcinoma